Circulating glycated albumin levels and gestational diabetes mellitus

作     者：Wei Xiong Zhao-Hui Zeng Yuan Xu Hui Li Hui Lin 

作者机构：Department of MedicalHunan Traditional Chinese Medical CollegeZhuzhou 412012Hunan ProvinceChina Department of OutpatientZhuzhou Second HospitalZhuzhou 412012Hunan ProvinceChina 

出 版 物：《World Journal of Diabetes》 (世界糖尿病杂志（英文版）（电子版）)

年 卷 期：2024年第15卷第8期

页      面：1802-1810页

学科分类：1002[医学-临床医学] 100211[医学-妇产科学] 10[医学] 

主　　题：Glycated albumin Gestational diabetes mellitus Diabetes mellitus Meta-analysis Weighted mean difference 

摘      要：BACKGROUND Gestational diabetes mellitus(GDM)is characterized by glucose intolerance that is first diagnosed during pregnancy,making it the most common complication associated with this *** detection and targeted treatment of GDM can minimize foetal exposure to maternal hyperglycaemia and subsequently reduce the associated adverse pregnancy *** studies have inconsistently suggested that the level of glycated albumin(GA)might predict *** To review and synthesize existing evidence to evaluate the relationship between GA levels and the development of *** We sought to compare GA levels between GDM and control groups in this metaanalysis by systematically searching the Web of Science,PubMed,Cochrane Library,and Embase databases for articles published up to June *** analysis utilized the weighted mean difference(WMD)as the primary *** data were meticulously extracted,and the quality of the included studies was ***,we conducted a subgroup analysis based on study region and sample *** assessed heterogeneity using I2 statistics and evaluated publication bias through funnel ***,trim-and-fill analysis was employed to detect and address any potential publication *** The meta-analysis included a total of 11 studies involving 5477 participants,comprising 1900 patients with GDM and 3577 control *** synthesized results revealed a notable correlation between elevated GA levels and increased susceptibility to *** calculated WMD was 0.42,with a 95%confidence interval(95%CI)ranging from 0.11 to 0.74,yielding a P value less than *** specific GA levels,the mean GA level in the GDM group was 12.6,while for the control group,it was lower,at *** discrepancy underscores the potential of GA as a biomarker for assessing GDM ***,we explored the levels of glycated haemoglobin(HbA1c)in both *** WMD for HbA1c was 0.19,with a 95%CI ranging from 0.15 to 0.